Picture of Cerevel Therapeutics Holdings logo

CERE — Cerevel Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Cerevel Therapeutics To Present At 41St Annual J.P. Morgan Healthcare Conference And Provide Pipeline Update

Jan 9 (Reuters) - Cerevel Therapeutics Holdings Inc
 CERE.O :
    * CEREVEL THERAPEUTICS TO PRESENT AT 41ST ANNUAL J.P. MORGAN
HEALTHCARE CONFERENCE AND PROVIDE PIPELINE UPDATE
    * CEREVEL THERAPEUTICS HOLDINGS INC - PHASE 2
PROOF-OF-CONCEPT
DARIGABAT PANIC DISORDER TRIAL TO BE INITIATED IN Q2 2023
    * CEREVEL THERAPEUTICS - MULTIPLE DATA READOUTS & CASH
RUNWAY INTO
2025 TO SUPPORT ADVANCEMENT OF DIVERSE PIPELINE OF NOVEL
NEUROSCIENCE DRUG CANDIDATES

Source text for Eikon:  ID:nGNX4hSHyB 
Further company coverage:  CERE.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cerevel Therapeutics Holdings

See all news